Compile Data Set for Download or QSAR
Report error Found 157 Enz. Inhib. hit(s) with all data for entry = 11310
TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606050(US11680060, Example 124)
Affinity DataIC50: 0.370nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606079(US11680060, Example 166)
Affinity DataIC50: 0.410nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605963(US11680060, Example 30)
Affinity DataIC50: 0.570nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606039(US11680060, Example 113)
Affinity DataIC50: 0.600nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605999(US11680060, Example 66)
Affinity DataIC50: 0.600nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605992(US11680060, Example 59)
Affinity DataIC50: 0.710nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605996(US11680060, Example 63)
Affinity DataIC50: 0.770nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606038(US11680060, Example 112)
Affinity DataIC50: 0.780nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606076(US11680060, Example 161)
Affinity DataIC50: 0.800nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606047(US11680060, Example 121)
Affinity DataIC50: 0.860nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606012(US11680060, Example 79 | US11680060, Example 94)
Affinity DataIC50: 0.860nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605971(US11680060, Example 38)
Affinity DataIC50: 0.900nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606055(US11680060, Example 129)
Affinity DataIC50: 0.900nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605969(US11680060, Example 36)
Affinity DataIC50: 0.930nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605945(US11680060, Example 6 | US11680060, Example 187 | ...)
Affinity DataIC50: 0.940nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606051(US11680060, Example 125)
Affinity DataIC50: 0.950nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606044(US11680060, Example 118)
Affinity DataIC50: 0.990nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606037(US11680060, Example 111)
Affinity DataIC50: 1nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605988(US11680060, Example 55)
Affinity DataIC50: 1nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606020(US11680060, Example 89)
Affinity DataIC50: 1nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606029(US11680060, Example 100)
Affinity DataIC50: 1nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606041(US11680060, Example 115)
Affinity DataIC50: 1.10nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605982(US11680060, Example 49)
Affinity DataIC50: 1.10nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606021(US11680060, Example 90)
Affinity DataIC50: 1.20nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606011(US11680060, Example 78)
Affinity DataIC50: 1.20nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606043(US11680060, Example 117)
Affinity DataIC50: 1.20nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605983(US11680060, Example 50)
Affinity DataIC50: 1.20nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605984(US11680060, Example 51)
Affinity DataIC50: 1.30nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605985(US11680060, Example 52)
Affinity DataIC50: 1.40nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605990(US11680060, Example 57)
Affinity DataIC50: 1.40nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605993(US11680060, Example 60)
Affinity DataIC50: 1.40nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606056(US11680060, Example 130)
Affinity DataIC50: 1.40nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606040(US11680060, Example 114)
Affinity DataIC50: 1.40nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606063(US11680060, Example 137)
Affinity DataIC50: 1.40nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605981(US11680060, Example 48)
Affinity DataIC50: 1.40nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606045(US11680060, Example 119)
Affinity DataIC50: 1.40nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606080(US11680060, Example 167 | BDBM606081)
Affinity DataIC50: 1.5nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606000(US11680060, Example 67 | US11680060, Example 68)
Affinity DataIC50: 1.5nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606075(US11680060, Example 160)
Affinity DataIC50: 1.60nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605998(US11680060, Example 65)
Affinity DataIC50: 1.60nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606053(US11680060, Example 127)
Affinity DataIC50: 1.70nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605995(US11680060, Example 62)
Affinity DataIC50: 1.70nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606012(US11680060, Example 79 | US11680060, Example 94)
Affinity DataIC50: 1.70nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606054(US11680060, Example 128)
Affinity DataIC50: 1.80nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606026(US11680060, Example 95)
Affinity DataIC50: 1.80nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606057(US11680060, Example 131)
Affinity DataIC50: 1.80nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM606019(US11680060, Example 87)
Affinity DataIC50: 2nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605991(US11680060, Example 58)
Affinity DataIC50: 2nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605972(US11680060, Example 39)
Affinity DataIC50: 2nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM605970(US11680060, Example 37)
Affinity DataIC50: 2.10nMAssay Description:IP-One, Cisbio, cat #621PAPEC, is a commercially available assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
US Patent

Displayed 1 to 50 (of 157 total ) | Next | Last >>
Jump to: